Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2845 (LINC02845) is annotated as a long intergenic non-coding RNA, commonly abbreviated as a lincRNA. LincRNAs are a subclass of long non-coding RNAs that are defined by being longer than 200 nucleotides and by originating from genomic regions between protein-coding genes ("intergenic"). In general, lincRNAs have diverse regulatory roles in the genome, including remodeling chromatin, influencing gene expression, acting as enhancers, and modulating the expression of neighboring genes—with tissue specificity and diverse mechanisms suggested. However, there is no specific functional, clinical, or mechanistic data currently available for LINC02845 in peer-reviewed publications or reference genomic databases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2845 (LINC02845).